MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

MDT

83.58

-0.61%↓

VEEV

225.8

+0.45%↑

A

105.71

+0.08%↑

WBA

10.98

-0.18%↓

CHE

548.09

-0.97%↓

Search

Fresenius Medical Care AG & Co KGaA

Suletud

24.05 1.73

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

23.64

Max

24.17

Põhinäitajad

By Trading Economics

Sissetulek

-146M

119M

Müük

325M

5.1B

P/E

Sektori keskmine

22.615

57.333

Aktsiakasum

0.455

Dividenditootlus

2.73

Kasumimarginaal

2.338

Töötajad

111,513

EBITDA

-565M

281M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+16.12% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

2.73%

2.63%

Turustatistika

By TradingEconomics

Turukapital

224M

14B

Eelmine avamishind

22.32

Eelmine sulgemishind

24.05

Tehniline skoor

By Trading Central

Kindlus

Strong Bearish Evidence

Fresenius Medical Care AG & Co KGaA Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

21. märts 2025, 08:19 UTC

Market Talk

Fresenius Medical Care's Revenue Estimates Lowered by Jefferies on U.S. Volume Concerns -- Market Talk

25. veebr 2025, 10:27 UTC

Market Talk
Tulu

Fresenius Medical Care's U.S. Volume Growth Is Unlikely to Reassure Investors -- Market Talk

15. juuli 2024, 08:17 UTC

Market Talk

Fresenius Medical Care, DaVita Brace for Competition, Shift to Home Dialysis -- Market Talk

3. mai 2024, 08:20 UTC

Market Talk
Omandamised, ülevõtmised, äriostud

Fresenius' Disposal of Part of Its Rehabilitation Business Seems Positive -- Market Talk

Võrdlus sarnastega

Hinnamuutus

Fresenius Medical Care AG & Co KGaA Prognoos

Hinnasiht

By TipRanks

16.12% tõus

12 kuu keskmine prognoos

Keskmine 27.45 USD  16.12%

Kõrge 28.9 USD

Madal 26 USD

Põhineb 5 Wall Streeti analüütiku instrumendi Fresenius Medical Care AG & Co KGaA 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

5 ratings

2

Osta

3

Hoia

0

Müü

Tehniline skoor

By Trading Central

23.5 / 23.6799Toetus ja vastupanu

Lühikene perspektiiv

Strong Bearish Evidence

Keskpikk perspektiiv

Very Strong Bearish Evidence

Pikk perspektiiv

Weak Bearish Evidence

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Fresenius Medical Care AG & Co KGaA

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.